Ekf Diagnostics Holding PLC Stock Rating Reaffirmed by N+1 Singer (EKF)
Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating restated by analysts at N+1 Singer in a research report issued to clients and investors on Monday, AnalystRatingsNetwork reports. They currently have a GBX 35 ($0.58) price objective on the stock. N+1 Singer’s price objective points to a potential downside of 10.26% from the company’s current price.
Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note to investors on Monday, January 20th. They now have a GBX 42 ($0.69) price target on the stock.
Ekf Diagnostics Holding PLC (LON:EKF) traded down 0.32% during mid-day trading on Monday, hitting GBX 39.00. 354,622 shares of the company’s stock traded hands. Ekf Diagnostics Holding PLC has a 52-week low of GBX 23.75 and a 52-week high of GBX 43.00. The stock’s 50-day moving average is GBX 34.34 and its 200-day moving average is GBX 30..
EKF Diagnostics Holdings Plc, formerly International Brand Licensing plc, designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.